logo

EBS

Emergent·NYSE
--
--(--)
--
--(--)
7.66 / 10
Outperform

The security demonstrates solid fundamental health (7.7/10). Key positives include strong PB-ROE, Asset-MV, Revenue-MV, and Profit-MV metrics, while challenges lie in Net profit / Total profit (%) and Current assets turnover ratio. Overall, the fundamental profile is highly favorable for long-term investors.

Fundamental(7.66)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value1.13
Score3/3
Weight33.36%
1M Return20.82%
Inventory turnover ratio
Value0.72
Score2/3
Weight-2.46%
1M Return-2.63%
Gross profit margin (%)
Value59.39
Score2/3
Weight1.60%
1M Return1.47%
Profit-MV
Value2.21
Score3/3
Weight20.70%
1M Return12.18%
PB-ROE
Value-0.72
Score3/3
Weight15.23%
1M Return11.47%
Current assets turnover ratio
Value0.86
Score1/3
Weight-0.49%
1M Return-0.48%
Fixed assets turnover ratio
Value2.47
Score2/3
Weight0.13%
1M Return0.12%
Asset-MV
Value-0.50
Score3/3
Weight22.51%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight9.71%
1M Return7.73%
Net profit / Total profit (%)
Value80.30
Score0/3
Weight-0.29%
1M Return-0.30%
Is EBS undervalued or overvalued?
  • EBS scores 7.66/10 on fundamentals and holds a Discounted valuation at present. Backed by its 20.13% ROE, 9.62% net margin, 7.56 P/E ratio, 0.98 P/B ratio, and 136.32% earnings growth, these metrics solidify its Outperform investment rating.